TARS
Tarsus Pharmaceuticals, Inc.
$75.95−2.25 (−2.88%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Oct 16, 2020 – Nov 18, 2026, Dividends reinvested
- Final balance
- $36,905
- CAGR
- +23.92%
- Max drawdown
- −77.67%
Trailing returns (%)
TARS's average annual return was 24.74% over the last 5 years, through Nov 18, 2026. $10,000 in TARS on Nov 18, 2021 grew to $30,199 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +11.58%
- 3M
- +6.93%
- 6M
- +20.90%
- YTD
- −7.24%
- 1Y
- −1.33%
Per year
- 3Y
- +59.10%
- 5Y
- +24.74%
- Since 2020
- +23.92%
Annual returns
2020 from Oct 16 · 2026 through Nov 18
TARS returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −7.24% |
| 2025 | +47.88% |
| 2024 | +173.43% |
| 2023 | +38.13% |
| 2022 | −34.84% |
| 2021 | −45.56% |
| 2020 from Oct 16 | +100.83% |
Metrics
Since 2020| Volatility | 62.97% |
|---|---|
| Sharpe ratio | 0.66 |
| Sortino ratio | 0.99 |
| Calmar ratio | 0.31 |
| Longest drawdown | 3.9 years |
Worst drawdowns
Since 2020| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −77.7% | Dec 2020 | May 2022 | Nov 2024 | 3.9 years |
| −32.0% | Dec 2025 | Jul 2026 | Sep 2026 | 8 months |
| −31.8% | Feb 2025 | Jul 2025 | Aug 2025 | 7 months |
| −26.2% | Nov 2020 | Nov 2020 | Dec 2020 | 1 month |
| −25.6% | Sep 2026 | Nov 2026 | Not yet | 2 months so far |